Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.39 |
| ▸ | PARP1 | P09874 | 2/20 | 0.37 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.37 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.37 |
| ▸ | PARP11 | Q9NR21 | 1/20 | 0.37 |
| ▸ | HTR2C | P28335 | 2/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.37 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.37 |
| ▸ | NISCH | Q9Y2I1 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.34 |
| ▸ | HTR3B | O95264 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | HTR1A | P08908 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31668742 | 1.00 | HSD17B10 (0.42) | HSD17B10ALDH1A1TSHRCYP2A6TDP1 | |
| Iodide SCHEMBL29247920 | 0.98 | HSD17B10 (0.41) | HSD17B10ALDH1A1TSHRCYP2A6TDP1 | |
| SCHEMBL8714223 | 0.91 | HPRT1 (0.50) | HSD17B10ALDH1A1TSHRCYP2A6TDP1 | |
| SCHEMBL31456577 | 0.91 | HPRT1 (0.50) | HSD17B10ALDH1A1TSHRCYP2A6TDP1 | |
| Hydrochloric Acid SCHEMBL8713800 | 0.89 | HPRT1 (0.48) | HSD17B10ALDH1A1TSHRCYP2A6TDP1 | |
| SCHEMBL6725176 | 0.89 | CXCR4 (0.40) | HSD17B10ALDH1A1TSHRCYP2A6TDP1 | |
| SCHEMBL28732081 | 0.81 | NPC1 (0.58) | HSD17B10ALDH1A1PARP1PDPK1PARP10 | |
| SCHEMBL12799615 | 0.81 | HSD17B10 (0.39) | HSD17B10ALDH1A1TSHRCYP2A6TDP1 | |
| SCHEMBL21187674 | 0.80 | HPRT1 (0.47) | HSD17B10ALDH1A1TSHRCYP2A6TDP1 | |
| SCHEMBL4421747 | 0.79 | ALDH1A1 (0.46) | HSD17B10ALDH1A1TSHRCYP2A6TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 662 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4304842-B1 | METHOD FOR MAKING PHOTOFUNCTIONAL CONTACT LENSES | ALCON INC (CH) | 2026-05-06 | — | — | EP | claimed |
| EP-4347683-B1 | CURABLE PHOTOCHROMIC COMPOSITION | TRANSITIONS OPTICAL LTD (IE) | 2026-05-06 | — | — | EP | claimed |
| EP-4727984-A1 | CURABLE PHOTOCHROMIC COMPOSITIONS INCLUDING (METH)ACRYLATE, AMINE, AND ISOCYANATE FUNCTIONAL COMPONENTS | Transitions Optical, Ltd. (IE) | 2026-04-22 | — | — | EP | claimed |
| US-12570787-B2 | Curable compositions and articles prepared therefrom | TRANSITIONS OPTICAL, LTD. (IE) | 2026-03-10 | — | — | US | claimed |
| US-20250361353-A1 | Curable Photochromic Compositions Including Isocyanate and Imine Functional Components | TRANSITIONS OPTICAL LTD (IE) | 2025-11-27 | — | — | US | claimed |
| EP-4562458-A1 | CURABLE PHOTOCHROMIC COMPOSITIONS INCLUDING HYDRAZIDE AND CARBONYL FUNCTIONAL COMPONENTS | Transitions Optical, Ltd. (IE) | 2025-06-04 | — | — | EP | claimed |
| CN-118420518-B | Benzondolium salt and preparation method and application thereof | 南通大学附属医院 | 2025-05-09 | — | — | CN | claimed |
| EP-4547724-A1 | CURABLE PHOTOCHROMIC COMPOSITIONS INCLUDING ISOCYANATE AND IMINE FUNCTIONAL COMPONENTS | Transitions Optical, Ltd. (IE) | 2025-05-07 | — | — | EP | claimed |
| WO-2025070233-A1 | PHOTOSENSITIVE COMPOSITION, CURED PRODUCT, ELECTRONIC COMPONENT, AND METHOD FOR PRODUCING CURED PRODUCT | 東レ株式会社 | 2025-04-03 | — | — | WO | claimed |
| US-12247169-B2 | Method for making photochromic contact lenses | ALCON INC. (CH) | 2025-03-11 | — | — | US | claimed |
| EP-0800522-B1 | PHOTOCHROMIC DIARYL-3H-NAPHTHOPYRANES | RODENSTOCK OPTIK G (DE) | 2002-02-20 | — | — | EP | claimed |
| WO-2001004702-A1 | DRY PHOTOGRAPHIC PRINTING PROCESS | KROMOTEK LTD (IL) | 2001-01-18 | — | — | WO | claimed |
| US-5990305-A | Photochromic diaryl-3H-naphthopyrane | OPTISCHE WERKE G. RODENSTOCK (DE) | 1999-11-23 | — | — | US | claimed |
| US-5808044-A | Indocarbocyanine and benzindocarbocyanine phosphoramidites | PHARMACIA BIOTECH INC. (US) | 1998-09-15 | — | — | US | claimed |
| EP-0800522-A2 | PHOTOCHROMIC DIARYL-3H-NAPHTHOPYRANES | Optische Werke G. Rodenstock (DE) | 1997-10-15 | — | — | EP | claimed |
| WO-1997015565-A9 | PHOTOCHROMIC DIARYL-3H-NAPHTHOPYRANES | — | 1997-07-17 | — | — | WO | claimed |
| WO-1997015565-A2 | PHOTOCHROMIC DIARYL-3H-NAPHTHOPYRANES | OPTISCHE WERKE G. RODENSTOCK (DE) | 1997-05-01 | — | — | WO | claimed |
| EP-0272212-B1 | PROCESS FOR CONTINUALLY PRODUCING AZO OR HYDRAZONE DYES | CIBA-GEIGY AG (CH) | 1993-09-01 | — | — | EP | claimed |
| US-4925926-A | Preparation of cationic azo or hydrazone dyes in which the alkylation and the separation of the cationic dye are carried out continuously | CIBA-GEIGY CORPORATION (US) | 1990-05-15 | — | — | US | claimed |
| EP-0272212-A2 | Process for continually producing azo or hydrazone dyes | CIBA-GEIGY AG (CH) | 1988-06-22 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12570787-B2 | Curable compositions and articles prepared therefrom | EHMT2, EHMT1, BHMT2 | HSD17B10 2919/4885ALDH1A1 1039/4885TSHR 3505/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.